Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Asciminib Roll-over Study |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase4 | Argentina Austria Brazil Bulgaria Canada China Czechia France Germany Italy Malaysia Mexico Oman Poland Portugal Romania Russia South Korea Spain Turkey (Türkiye) United Kingdom United States Vietnam View all |
NCT04877522 |
Asciminib RMP Study |
Chronic Myeloid Leukemia | South Korea | NCT05943522 | |
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea |
Non-Small-Cell Lung Carcinoma | South Korea | NCT05703516 | |
CAR-T Long Term Follow Up (LTFU) Study |
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | Phase3 | Australia Austria Belgium Canada China Denmark Finland France Germany Greece Hong Kong Israel Italy Japan Norway Saudi Arabia Singapore South Korea Spain Taiwan United Kingdom United States View all |
NCT02445222 |
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab |
Extensive Stage Small Cell Lung Cancer | Phase1, Phase2 | Austria Canada China Czechia France Germany Hong Kong Israel Italy Netherlands Singapore South Korea Spain Taiwan United Kingdom United States View all |
NCT05142696 |
Special Drug Use-results Surveillance of Tafinlar/Mekinist |
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor | Japan | NCT06262919 | |
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
Metastatic Neuroendocrine Prostate Cancer | Phase1 | France Germany Italy Spain United Kingdom United States View all |
NCT06379217 |
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis |
Multiple Sclerosis | Phase4 | Germany Italy Poland Puerto Rico United Kingdom United States View all |
NCT06444113 |
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies |
Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma | Brazil | NCT05541341 | |
Iptacopan in Patients With ANCA Associated Vasculitis |
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis | Phase2 | Argentina Australia Austria Belgium Canada China Czechia Denmark France Germany Hungary Netherlands Spain Turkey (Türkiye) United Kingdom United States View all |
NCT06388941 |